| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_ffipsc69_promoter_n_RM_12_166_3 |
 |
 |
2 |
0.4 |
2.89E-04 |
SLC25A29,
EXD3,
MESP1 |
negative regulation of endodermal cell fate specification [BP],
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
acyl carnitine transmembrane transporter activity [MF],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
3'-5' exonuclease activity [MF],
sinus venosus morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_37_6 |
 |
 |
5 |
1.0 |
3.23E-04 |
WASL,
NACC2 |
cellular protein complex localization [BP] |
| CG_ffipsc69_promoter_n_RM_14_16_2 |
 |
 |
2 |
0.4 |
2.28E-04 |
FBLN5,
TK2 |
deoxycytidine kinase activity [MF],
thymidine kinase activity [MF],
elastic fiber [CC],
deoxycytidine metabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_212_11 |
 |
 |
9 |
1.0 |
2.99E-04 |
MED24,
AHCTF1,
SURF6 |
nucleoplasm part [CC],
nucleoplasm [CC] |
| CG_ffipsc69_promoter_n_RM_14_41_3 |
 |
 |
3 |
0.4 |
4.60E-04 |
SLC35B2 |
3'-phosphoadenosine 5'-phosphosulfate transport [BP],
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_265_8 |
 |
 |
3 |
0.4 |
4.29E-04 |
AK8,
RBM22,
STRADA,
HNRPLL,
ACSL1 |
regulation of fatty acid oxidation [BP],
positive regulation of RNA splicing [BP],
ventricular system development [BP],
protein kinase activator activity [MF] |
| CG_ffipsc69_promoter_n_RM_14_26_2 |
 |
 |
4 |
0.6 |
4.15E-04 |
RUNX1,
NKX3-1,
MGEA5 |
positive regulation of androgen secretion [BP],
positive regulation of progesterone secretion [BP],
negative regulation of cardiac muscle adaptation [BP],
MADS box domain binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_267_3 |
 |
 |
2 |
0.4 |
4.18E-04 |
NAMPT |
nicotinamide phosphoribosyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_256_6 |
 |
 |
3 |
0.6 |
4.92E-04 |
NUP153 |
viral penetration into host nucleus [BP],
negative regulation of RNA export from nucleus [BP] |
| CG_ffipsc69_promoter_n_RM_12_112_9 |
 |
 |
4 |
0.8 |
3.33E-04 |
STAT3,
STAT4 |
JAK-STAT cascade [BP] |
| CG_ffipsc69_promoter_n_RM_12_235_4 |
 |
 |
3 |
0.4 |
3.92E-04 |
MYH9,
NUP153 |
protein anchor [MF] |
| CG_ffipsc69_promoter_n_RM_12_200_5 |
 |
 |
5 |
0.8 |
2.60E-04 |
WNT3 |
Spemann organizer formation at the anterior end of the primitive streak [BP] |
| CG_ffipsc69_promoter_n_RM_12_218_7 |
 |
 |
5 |
1.0 |
2.10E-04 |
CHRM4 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_12_91_4 |
 |
 |
4 |
0.8 |
3.29E-04 |
ALG3,
TRPT1,
SP8 |
dorsal/ventral pattern formation [BP],
tRNA 2'-phosphotransferase activity [MF],
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_95_2 |
 |
 |
4 |
0.8 |
2.72E-04 |
NTRK3 |
modulation by virus of host transcription [BP],
positive regulation of axon extension involved in regeneration [BP] |
| CG_ffipsc69_promoter_n_RM_14_43_3 |
 |
 |
3 |
0.6 |
4.21E-04 |
FKBP1A |
'de novo' protein folding [BP] |
| CG_ffipsc69_promoter_n_RM_12_106_4 |
 |
 |
3 |
0.6 |
2.59E-04 |
NUDT3,
NIN,
CSAD,
KDM5B,
NFS1 |
sulfinoalanine decarboxylase activity [MF],
diphosphoinositol polyphosphate catabolic process [BP],
centrosome-templated microtubule nucleation [BP],
pyridoxal phosphate binding [MF],
diadenosine polyphosphate catabolic process [BP],
histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP],
histone demethylase activity (H3-trimethyl-K4 specific) [MF],
sulfur amino acid metabolic process [BP],
cysteine desulfurase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_221_8 |
 |
 |
3 |
0.6 |
1.91E-04 |
ICMT |
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_214_8 |
 |
 |
3 |
0.6 |
3.15E-04 |
RAB3A,
DLG4 |
synaptic vesicle maturation [BP] |
| CG_ffipsc69_promoter_n_RM_14_24_3 |
 |
 |
2 |
0.4 |
1.12E-04 |
POU6F1,
EBF1,
ZFP82,
CITED1 |
transcription, DNA-dependent [BP],
response to interleukin-9 [BP],
response to interleukin-11 [BP] |
| CG_ffipsc69_promoter_n_RM_12_21_6 |
 |
 |
2 |
0.4 |
3.70E-04 |
SNAPC4 |
snRNA-activating protein complex [CC],
snRNA transcription from RNA polymerase III promoter [BP],
snRNA transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc69_promoter_n_RM_14_28_5 |
 |
 |
2 |
0.4 |
3.25E-04 |
HDDC3 |
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_162_8 |
 |
 |
3 |
0.6 |
1.98E-04 |
HAAO,
PAX6 |
forebrain-midbrain boundary formation [BP],
commitment of neuronal cell to specific neuron type in forebrain [BP],
pancreatic A cell development [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
3-hydroxyanthranilate 3,4-dioxygenase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_273_4 |
 |
 |
4 |
0.8 |
2.23E-04 |
TBC1D8,
GDI2 |
Rab GTPase activator activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_250_9 |
 |
 |
6 |
1.0 |
4.55E-04 |
RNGTT,
POLR2L |
7-methylguanosine mRNA capping [BP] |
| CG_ffipsc69_promoter_n_RM_12_100_7 |
 |
 |
3 |
0.6 |
4.67E-04 |
DENND5A,
DENND6B |
Rab guanyl-nucleotide exchange factor activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_24_8 |
 |
 |
5 |
1.0 |
2.88E-04 |
CSDA |
positive regulation of cytoplasmic translation [BP] |
| CG_ffipsc69_promoter_n_RM_12_10_8 |
 |
 |
4 |
0.8 |
3.25E-04 |
IRF7,
WNT10B |
myoblast cell differentiation involved in skeletal muscle regeneration [BP],
regulation of MyD88-independent toll-like receptor signaling pathway [BP],
positive regulation of anagen [BP] |
| CG_ffipsc69_promoter_n_RM_12_135_6 |
 |
 |
2 |
0.4 |
1.65E-04 |
ARHGDIA |
Rho GDP-dissociation inhibitor activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_93_9 |
 |
 |
5 |
1.0 |
3.32E-04 |
HOXA7,
FOXL2,
PAX3,
NEUROG2,
POU2F2,
ZC3H8 |
sequence-specific DNA binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_35_9 |
 |
 |
4 |
0.8 |
4.10E-04 |
ESR2,
ZBTB4,
MNX1,
HOXB1,
SIX1,
PARP1,
NUP153,
ARGLU1,
MAFA,
ZNF516,
YBX2,
ZC3H8 |
polysome [CC],
regulation of transcription, DNA-dependent [BP],
sequence-specific DNA binding [MF],
facial nerve morphogenesis [BP],
DNA binding [MF],
nerve development [BP] |
| CG_ffipsc69_promoter_n_RM_12_282_5 |
 |
 |
4 |
0.6 |
1.81E-04 |
TBX5 |
cell migration involved in coronary vasculogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_128_11 |
 |
 |
2 |
0.4 |
1.16E-04 |
STRA13,
C1orf86 |
Fanconi anaemia nuclear complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_182_6 |
 |
 |
5 |
0.8 |
4.16E-04 |
JUP |
protein-DNA complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_194_6 |
 |
 |
6 |
1.0 |
3.08E-04 |
SYT6 |
clathrin binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_127_6 |
 |
 |
4 |
0.6 |
2.37E-04 |
PGM3,
BCL11B,
GBGT1 |
globoside alpha-N-acetylgalactosaminyltransferase activity [MF],
phosphoacetylglucosamine mutase activity [MF],
striatal medium spiny neuron differentiation [BP],
olfactory bulb axon guidance [BP] |
| CG_ffipsc69_promoter_n_RM_12_48_6 |
 |
 |
4 |
0.6 |
3.30E-04 |
SLC40A1 |
spleen trabecula formation [BP] |
| CG_ffipsc69_promoter_n_RM_14_38_2 |
 |
 |
5 |
0.4 |
5.76E-04 |
PIEZO1,
GSK3A,
NGLY1 |
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [MF],
negative regulation of type B pancreatic cell development [BP],
negative regulation of cell growth involved in cardiac muscle cell development [BP],
positive regulation of adrenergic receptor signaling pathway [BP],
negative regulation of UDP-glucose catabolic process [BP],
mechanically-gated ion channel activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_99_8 |
 |
 |
7 |
1.0 |
2.99E-04 |
EIF5A2,
PRDX3,
TSHZ3 |
polyamine homeostasis [BP],
alkyl hydroperoxide reductase activity [MF],
ureteric peristalsis [BP] |
| CG_ffipsc69_promoter_n_RM_12_185_8 |
 |
 |
4 |
0.8 |
2.57E-04 |
SYT6,
TNFRSF10A,
CDC42BPG,
SNCA,
HIP1,
SOS1 |
phospholipid binding [MF],
activation of cysteine-type endopeptidase activity involved in apoptotic process [BP],
clathrin binding [MF],
clathrin-coated vesicle [CC] |
| CG_ffipsc69_promoter_n_RM_12_275_9 |
 |
 |
4 |
0.8 |
2.87E-04 |
ACD,
TERT |
telomere maintenance via telomerase [BP],
telomeric template RNA reverse transcriptase activity [MF],
nuclear telomere cap complex [CC],
positive regulation of single-stranded telomeric DNA binding [BP],
telomere assembly [BP] |
| CG_ffipsc69_promoter_n_RM_12_268_11 |
 |
 |
7 |
1.0 |
4.87E-04 |
SDF4 |
zymogen granule exocytosis [BP] |
| CG_ffipsc69_promoter_n_RM_14_40_14 |
 |
 |
10 |
0.8 |
5.44E-04 |
KDM2B,
TOP2B,
HAND2,
TFAP2A |
neural crest cell development [BP],
forebrain development [BP] |
| CG_ffipsc69_promoter_n_RM_12_147_4 |
 |
 |
5 |
0.8 |
2.52E-04 |
HIBADH,
MAP6D1,
GCLC,
DVL1 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
3-hydroxyisobutyrate dehydrogenase activity [MF],
N-terminal peptidyl-L-cysteine N-palmitoylation [BP] |
| CG_ffipsc69_promoter_n_RM_12_243_8 |
 |
 |
5 |
1.0 |
2.56E-04 |
BAD |
phosphatidylinositol-mediated signaling [BP] |
| CG_ffipsc69_promoter_n_RM_12_150_2 |
 |
 |
3 |
0.6 |
2.22E-04 |
EARS2 |
glutamate-tRNA(Gln) ligase activity [MF],
glutamate-tRNA ligase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_199_9 |
 |
 |
2 |
0.4 |
3.05E-04 |
CDC25A,
PPID,
BSCL2,
ALG2 |
protein glycosylation in endoplasmic reticulum [BP],
cellular response to UV [BP],
GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF],
lipid particle organization [BP] |
| CG_ffipsc69_promoter_n_RM_12_52_7 |
 |
 |
6 |
0.8 |
3.20E-04 |
GNB1 |
cardiac muscle cell apoptotic process [BP] |
| CG_ffipsc69_promoter_n_RM_14_36_2 |
 |
 |
4 |
0.6 |
4.16E-04 |
OARD1,
DICER1 |
peripheral nervous system myelin formation [BP],
zygote asymmetric cell division [BP],
regulation of enamel mineralization [BP],
positive regulation of Schwann cell differentiation [BP],
deacetylase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_146_4 |
 |
 |
4 |
0.8 |
3.79E-04 |
DAP,
KLK14,
TRMT61B,
GLI3 |
mitochondrial tRNA methylation [BP],
anterior semicircular canal development [BP],
lambdoid suture morphogenesis [BP],
cellular response to amino acid starvation [BP],
sagittal suture morphogenesis [BP],
lateral ganglionic eminence cell proliferation [BP],
seminal clot liquefaction [BP],
lateral semicircular canal development [BP] |
| CG_ffipsc69_promoter_n_RM_12_227_4 |
 |
 |
3 |
0.6 |
2.13E-04 |
NAE1,
TCF3,
TOP2A,
TAF13 |
viral integration complex [CC],
DNA topoisomerase complex (ATP-hydrolyzing) [CC],
positive regulation of retroviral genome replication [BP],
protein heterodimerization activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_2_9 |
 |
 |
6 |
1.0 |
2.89E-04 |
CHDH,
CSTB |
choline dehydrogenase activity [MF],
negative regulation of peptidase activity [BP],
negative regulation of endopeptidase activity [BP] |
| CG_ffipsc69_promoter_n_RM_12_231_7 |
 |
 |
3 |
0.4 |
3.71E-04 |
CD34 |
glomerular endothelium fenestra [CC] |
| CG_ffipsc69_promoter_n_RM_12_186_4 |
 |
 |
2 |
0.4 |
1.72E-04 |
SLC25A29,
PPAP2A,
NR1I3 |
androgen receptor signaling pathway [BP],
acyl carnitine transmembrane transporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_14_4_6 |
 |
 |
4 |
0.6 |
4.69E-04 |
PCGF6,
CBX8 |
PRC1 complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_30_6 |
 |
 |
3 |
0.6 |
3.19E-04 |
LONP1,
SIX4,
DLL1,
HAND2,
KIF3A,
CLPX |
ATP-dependent peptidase activity [MF],
determination of left/right symmetry [BP],
thymus development [BP],
mitochondrial nucleoid [CC] |
| CG_ffipsc69_promoter_n_RM_12_32_6 |
 |
 |
3 |
0.6 |
3.83E-04 |
HDDC3,
HEY1,
SLC19A1 |
atrioventricular valve formation [BP],
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF],
umbilical cord morphogenesis [BP],
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP],
methotrexate transport [BP],
methotrexate transporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_14_7_7 |
 |
 |
4 |
0.4 |
3.94E-04 |
LHX3,
SOS2,
NKX2-8,
HOXA1,
GAS1,
NEUROG2,
SP8 |
axonogenesis [BP],
axon guidance [BP],
dorsal/ventral pattern formation [BP],
central nervous system neuron differentiation [BP],
motor neuron axon guidance [BP],
outer ear morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_237_7 |
 |
 |
3 |
0.6 |
1.57E-04 |
BCL11B,
TFAP2A |
keratinocyte development [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_53_10 |
 |
 |
3 |
0.6 |
2.25E-04 |
GCNT4,
OAT,
NKX3-2,
MESP1,
ITPK1 |
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF],
negative regulation of endodermal cell fate specification [BP],
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
inter-male aggressive behavior [BP],
ornithine-oxo-acid transaminase activity [MF],
inositol tetrakisphosphate 1-kinase activity [MF],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
organ formation [BP],
sinus venosus morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_154_5 |
 |
 |
5 |
0.8 |
3.93E-04 |
WNT3 |
Spemann organizer formation at the anterior end of the primitive streak [BP] |
| CG_ffipsc69_promoter_n_RM_12_119_5 |
 |
 |
8 |
1.0 |
1.63E-04 |
CLSTN1,
GJC1,
PIGP |
endoplasmic reticulum membrane [CC] |
| CG_ffipsc69_promoter_n_RM_12_180_4 |
 |
 |
4 |
0.6 |
2.97E-04 |
NODAL,
PLXNB1,
GALNS,
AMIGO1 |
transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP],
positive regulation of axonogenesis [BP],
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP],
axial mesodermal cell fate specification [BP],
N-acetylgalactosamine-6-sulfatase activity [MF],
inhibition of neuroepithelial cell differentiation [BP] |
| CG_ffipsc69_promoter_n_RM_12_66_4 |
 |
 |
6 |
0.8 |
3.08E-04 |
ATP6V1E2,
ATP6V1E1,
PSMA5,
POLE |
proton-transporting two-sector ATPase complex, catalytic domain [CC],
proton-transporting ATPase activity, rotational mechanism [MF],
hydrogen-exporting ATPase activity, phosphorylative mechanism [MF],
ATP hydrolysis coupled proton transport [BP],
S phase of mitotic cell cycle [BP],
transferrin transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_195_5 |
 |
 |
4 |
0.8 |
2.44E-04 |
UCN,
PRKACA,
HOXA1,
CNR1,
PAX5 |
regulation of behavior [BP],
regulation of feeding behavior [BP],
activation of protein kinase A activity [BP],
neuron projection development [BP],
negative regulation of blood pressure [BP],
regulation of synaptic transmission, glutamatergic [BP],
motor neuron axon guidance [BP],
cell differentiation [BP],
nervous system development [BP] |
| CG_ffipsc69_promoter_n_RM_12_203_8 |
 |
 |
7 |
1.0 |
4.14E-04 |
TGFB3 |
detection of hypoxia [BP] |
| CG_ffipsc69_promoter_n_RM_12_31_6 |
 |
 |
3 |
0.6 |
2.38E-04 |
CRAT,
MAD1L1 |
carnitine O-acetyltransferase activity [MF],
mitotic telophase [BP] |
| CG_ffipsc69_promoter_n_RM_12_264_8 |
 |
 |
3 |
0.6 |
3.35E-04 |
CCNE2,
GNG12,
ADCY3,
MCM7 |
cellular response to glucagon stimulus [BP],
DNA replication initiation [BP],
cyclin-dependent protein kinase regulator activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_270_4 |
 |
 |
1 |
0.2 |
1.79E-04 |
KDM2B |
third ventricle development [BP],
fourth ventricle development [BP],
initiation of neural tube closure [BP] |
| CG_ffipsc69_promoter_n_RM_14_17_3 |
 |
 |
9 |
1.0 |
2.79E-04 |
TUBB2A,
CCT4,
IL12RB1 |
interleukin-12 receptor complex [CC],
'de novo' posttranslational protein folding [BP],
interleukin-12 receptor activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_279_7 |
 |
 |
4 |
0.8 |
2.33E-04 |
GNB1,
RPS6KA2 |
cardiac muscle cell apoptotic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_34_6 |
 |
 |
7 |
0.8 |
3.00E-04 |
SLC39A6 |
cellular zinc ion homeostasis [BP] |
| CG_ffipsc69_promoter_n_RM_12_38_13 |
 |
 |
4 |
0.8 |
2.10E-04 |
HMGB1,
CNR1 |
inflammatory response to antigenic stimulus [BP],
response to cocaine [BP] |
| CG_ffipsc69_promoter_n_RM_12_92_7 |
 |
 |
4 |
0.8 |
4.01E-04 |
ELAVL1,
MEX3D |
AU-rich element binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_280_7 |
 |
 |
4 |
0.8 |
1.08E-04 |
MB21D1 |
cyclic-GMP-AMP synthase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_84_7 |
 |
 |
6 |
0.8 |
3.62E-04 |
BCAT2 |
isoleucine catabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_14_25_9 |
 |
 |
7 |
1.0 |
6.48E-05 |
CHORDC1,
PPID |
chaperone-mediated protein folding [BP],
Hsp90 protein binding [MF],
cellular response to UV-A [BP],
negative regulation of Rho-dependent protein serine/threonine kinase activity [BP] |
| CG_ffipsc69_promoter_n_RM_16_1_9 |
 |
 |
9 |
1.0 |
3.45E-04 |
JAKMIP2,
EXT1,
ZDHHC7,
CUL3,
PDE4DIP |
Golgi apparatus [CC],
glucuronosyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_257_9 |
 |
 |
5 |
0.8 |
3.30E-04 |
BMP4,
TCF3,
BCOR,
COL12A1 |
BMP signaling pathway involved in renal system segmentation [BP],
bud dilation involved in lung branching [BP],
negative regulation of cell proliferation involved in heart morphogenesis [BP],
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP],
negative regulation of histone H3-K36 methylation [BP],
negative regulation of glomerulus development [BP],
positive regulation of neuron differentiation [BP],
negative regulation of mesenchymal cell proliferation involved in ureter development [BP],
collagen type XII [CC],
negative regulation of metanephric comma-shaped body morphogenesis [BP],
BMP signaling pathway involved in ureter morphogenesis [BP],
positive regulation of muscle cell differentiation [BP],
pulmonary artery endothelial tube morphogenesis [BP],
BMP signaling pathway involved in nephric duct formation [BP],
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP],
negative regulation of metanephric S-shaped body morphogenesis [BP],
intermediate mesodermal cell differentiation [BP],
T cell differentiation in thymus [BP],
ureter epithelial cell differentiation [BP],
positive regulation of cardiac muscle fiber development [BP] |
| CG_ffipsc69_promoter_n_RM_12_115_5 |
 |
 |
6 |
1.0 |
3.65E-04 |
NDN,
STX5,
APBB1,
SEMA6A,
STX1B |
SNAP receptor activity [MF],
neuron migration [BP] |
| CG_ffipsc69_promoter_n_RM_14_11_4 |
 |
 |
2 |
0.4 |
2.48E-04 |
PITPNA,
AKR7A3 |
stearic acid binding [MF],
aflatoxin catabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_36_6 |
 |
 |
4 |
0.6 |
2.73E-04 |
JAG2 |
gamma-delta T cell differentiation [BP] |
| CG_ffipsc69_promoter_n_RM_12_41_3 |
 |
 |
6 |
0.8 |
2.06E-04 |
TOLLIP,
MTNR1A |
interleukin-18 receptor complex [CC],
melatonin receptor activity [MF],
interleukin-1, Type I receptor binding [MF] |
| CG_ffipsc69_promoter_n_RM_16_4_1 |
 |
 |
4 |
0.4 |
1.51E-04 |
ISYNA1 |
inositol-3-phosphate synthase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_224_12 |
 |
 |
3 |
0.6 |
4.23E-04 |
NCL,
PLCD1,
POLG2 |
angiogenesis [BP],
mitochondrial chromosome [CC] |
| CG_ffipsc69_promoter_n_RM_12_159_6 |
 |
 |
3 |
0.6 |
3.25E-04 |
DAPK3,
SLC43A2,
CDK5,
SLC9A3,
CNR1 |
regulation of actin cytoskeleton reorganization [BP],
acetylcholine receptor activator activity [MF],
response to cocaine [BP],
ion transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_134_4 |
 |
 |
5 |
1.0 |
2.51E-04 |
RGS7,
GIT1,
PDE6D,
AGO2,
EIF4E3 |
regulation of G-protein coupled receptor protein signaling pathway [BP],
mRNA cap binding complex [CC],
regulation of GTP catabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_272_7 |
 |
 |
3 |
0.6 |
2.35E-04 |
PIAS2,
DPF1,
TAF1D,
TBX20,
ANP32A,
EPHA2,
TRIM35,
ACD,
HOXA11,
MDGA1,
TBX5,
RRP9,
FOXH1,
PHLDA1,
GAS7,
KIAA0319,
SFRP2 |
cardiac right ventricle morphogenesis [BP],
negative regulation of epithelial to mesenchymal transition [BP],
axial mesoderm development [BP],
atrial septum development [BP],
induction of apoptosis [BP],
post-anal tail morphogenesis [BP],
outflow tract morphogenesis [BP],
regulation of transcription, DNA-dependent [BP],
negative regulation of androgen receptor signaling pathway [BP],
pattern specification process [BP],
RNA metabolic process [BP],
small nucleolar ribonucleoprotein complex [CC],
positive regulation of apoptotic process [BP],
positive regulation of cardiac muscle cell proliferation [BP],
embryonic limb morphogenesis [BP],
cardiac left ventricle morphogenesis [BP],
mesodermal cell fate specification [BP],
pericardium development [BP],
morphogenesis of an epithelium [BP],
cardiac chamber formation [BP],
neuron migration [BP],
embryo development [BP] |
| CG_ffipsc69_promoter_n_RM_12_44_6 |
 |
 |
3 |
0.4 |
3.94E-04 |
TCFL5 |
regulation of cell differentiation [BP] |
| CG_ffipsc69_promoter_n_RM_12_96_5 |
 |
 |
5 |
0.8 |
1.30E-04 |
HOXA5,
DEGS2,
WT1 |
cell-cell signaling involved in mammary gland development [BP],
sphingolipid delta-4 desaturase activity [MF],
sphingosine hydroxylase activity [MF],
negative regulation of metanephric glomerular mesangial cell proliferation [BP] |
| CG_ffipsc69_promoter_n_RM_14_1_2 |
 |
 |
7 |
0.8 |
4.77E-04 |
TSHZ3,
PRKCQ |
positive regulation of T-helper 2 cell activation [BP],
musculoskeletal movement [BP],
ureteric peristalsis [BP] |
| CG_ffipsc69_promoter_n_RM_12_138_11 |
 |
 |
7 |
1.0 |
4.22E-04 |
PNPLA8,
CD24,
NUDT3 |
diphosphoinositol polyphosphate catabolic process [BP],
B cell receptor transport into membrane raft [BP],
diadenosine polyphosphate catabolic process [BP],
negative regulation of transforming growth factor beta3 production [BP],
chemokine receptor transport out of membrane raft [BP],
phosphatidylethanolamine catabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_148_8 |
 |
 |
1 |
0.2 |
1.56E-04 |
GALNS |
N-acetylgalactosamine-4-sulfatase activity [MF],
N-acetylgalactosamine-6-sulfatase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_68_4 |
 |
 |
5 |
0.8 |
1.64E-04 |
HOXA1,
MDC1 |
optokinetic behavior [BP],
abducens nerve formation [BP],
FHA domain binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_197_9 |
 |
 |
3 |
0.6 |
9.51E-05 |
UROS |
uroporphyrinogen III biosynthetic process [BP],
cellular response to amine stimulus [BP],
uroporphyrinogen-III synthase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_71_8 |
 |
 |
5 |
1.0 |
3.53E-04 |
LUZP1,
HOXA1,
MFSD10 |
neural fold bending [BP],
optokinetic behavior [BP],
tetracycline transporter activity [MF],
abducens nerve formation [BP],
artery development [BP],
tetracycline transport [BP] |
| CG_ffipsc69_promoter_n_RM_14_15_4 |
 |
 |
6 |
0.8 |
3.63E-04 |
PLXND1,
ECD,
EIF2B3,
EPHB4,
EFNB2 |
endothelial cell migration [BP],
response to glucose stimulus [BP],
regulation of glycolysis [BP],
cell migration involved in sprouting angiogenesis [BP],
ephrin receptor signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_12_266_10 |
 |
 |
4 |
0.6 |
2.52E-04 |
BAG6 |
ubiquitin-dependent protein catabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_49_7 |
 |
 |
7 |
1.0 |
2.54E-04 |
DPM3 |
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP] |
| CG_ffipsc69_promoter_n_RM_12_130_6 |
 |
 |
5 |
1.0 |
3.21E-04 |
MGEA5,
MKX,
NACC2 |
tendon sheath development [BP],
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of cardiac muscle adaptation [BP] |
| CG_ffipsc69_promoter_n_RM_14_37_2 |
 |
 |
3 |
0.4 |
2.36E-04 |
HYAL2,
L2HGDH,
YWHAG,
HID1 |
receptor tyrosine kinase binding [MF],
extrinsic to Golgi membrane [CC],
2-hydroxyglutarate dehydrogenase activity [MF],
response to antibiotic [BP],
response to brefeldin A [BP],
receptor signaling protein tyrosine kinase inhibitor activity [MF] |
| CG_ffipsc69_promoter_n_RM_16_9_3 |
 |
 |
6 |
0.8 |
5.57E-04 |
HAND2,
SLC1A2,
NFIB |
multicellular organismal aging [BP],
negative regulation of DNA binding [BP] |
| CG_ffipsc69_promoter_n_RM_12_236_6 |
 |
 |
3 |
0.4 |
9.63E-05 |
HAAO,
SLC25A11,
MLXIPL |
3-hydroxyanthranilate 3,4-dioxygenase activity [MF],
glucose mediated signaling pathway [BP],
carbohydrate response element binding [MF],
oxoglutarate:malate antiporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_183_7 |
 |
 |
5 |
0.8 |
3.11E-04 |
TPK1 |
thiamine diphosphate biosynthetic process [BP],
thiamine diphosphokinase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_6_4 |
 |
 |
4 |
0.8 |
3.65E-04 |
HOXA2,
LAMB1,
DUSP1,
WNT11,
DUSP18,
GSC |
middle ear morphogenesis [BP],
MAP kinase tyrosine/serine/threonine phosphatase activity [MF],
embryonic skeletal system development [BP],
non-canonical Wnt receptor signaling pathway [BP],
laminin-2 complex [CC],
laminin-8 complex [CC],
protein tyrosine/serine/threonine phosphatase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_103_9 |
 |
 |
4 |
0.6 |
2.29E-04 |
HAUS3,
ROCK2,
IPMK |
inositol tetrakisphosphate 3-kinase activity [MF],
centrosome organization [BP],
inositol-1,4,5-trisphosphate 6-kinase activity [MF],
negative regulation of angiogenesis [BP],
positive regulation of centrosome duplication [BP] |
| CG_ffipsc69_promoter_n_RM_12_189_16 |
 |
 |
8 |
1.0 |
3.56E-04 |
GRIK3,
RANGAP1,
ADA,
REV1 |
deoxycytidyl transferase activity [MF],
dendrite cytoplasm [CC],
Ran GTPase activator activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_276_8 |
 |
 |
4 |
0.6 |
6.17E-04 |
TACR3 |
tachykinin receptor activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_62_3 |
 |
 |
3 |
0.6 |
2.33E-04 |
CSAD,
SPTLC1,
NELFE |
taurine biosynthetic process [BP],
sulfinoalanine decarboxylase activity [MF],
SPOTS complex [CC],
pyridoxal phosphate binding [MF],
sphinganine biosynthetic process [BP],
NELF complex [CC] |
| CG_ffipsc69_promoter_n_RM_14_9_2 |
 |
 |
5 |
0.8 |
3.99E-04 |
PPA2 |
diphosphate metabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_118_10 |
 |
 |
6 |
1.0 |
4.57E-04 |
PPP2CA,
SMAD7,
EPHA7,
LDB1,
FOXL2,
JAK3,
PAX3,
RNASEL,
MTA2,
HIRA |
regulation of protein autophosphorylation [BP],
negative regulation of epithelial to mesenchymal transition [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc69_promoter_n_RM_12_274_7 |
 |
 |
4 |
0.8 |
4.57E-04 |
ATP2A3,
JSRP1 |
sarcoplasmic reticulum membrane [CC] |
| CG_ffipsc69_promoter_n_RM_12_105_7 |
 |
 |
5 |
1.0 |
5.02E-04 |
CSRNP1,
STAT5B,
ALDH6A1,
SSBP3,
ANKRD11,
TFAP2A |
head morphogenesis [BP],
valine metabolic process [BP],
face morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_51_9 |
 |
 |
7 |
1.0 |
3.72E-04 |
GABPB1,
STAT1,
HR,
NR2F6,
CBFA2T3,
OTX2,
CXCR4,
SHH,
NEUROG1,
ZFHX2,
IRX3,
HLA-DMA,
TGFBR3 |
positive thymic T cell selection [BP],
metanephric mesenchymal cell proliferation involved in metanephros development [BP],
positive regulation of T cell differentiation [BP],
positive regulation of oligodendrocyte differentiation [BP],
inner ear development [BP],
metanephros development [BP],
sequence-specific DNA binding transcription factor activity [MF],
coreceptor activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_109_10 |
 |
 |
5 |
1.0 |
2.81E-04 |
CDCA5,
PSRC1 |
mitotic metaphase plate congression [BP] |
| CG_ffipsc69_promoter_n_RM_14_5_2 |
 |
 |
3 |
0.6 |
6.39E-04 |
TSC1,
PPP6R1 |
regulation of phosphoprotein phosphatase activity [BP],
rRNA export from nucleus [BP] |
| CG_ffipsc69_promoter_n_RM_12_57_12 |
 |
 |
7 |
0.8 |
2.85E-04 |
CEBPA,
SERP1 |
positive regulation of fat cell differentiation [BP],
brown fat cell differentiation [BP],
plasma membrane organization [BP] |
| CG_ffipsc69_promoter_n_RM_12_120_7 |
 |
 |
8 |
1.0 |
3.99E-04 |
PARP1,
PARP16 |
NAD+ ADP-ribosyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_181_4 |
 |
 |
3 |
0.4 |
4.64E-04 |
AMIGO3,
H2AFX,
NUDT18,
TCFL5,
PVRL1 |
GDP catabolic process [BP],
male germ cell nucleus [CC],
8-oxo-dGDP phosphatase activity [MF],
8-oxo-GDP phosphatase activity [MF],
dADP catabolic process [BP],
dGDP catabolic process [BP],
heterophilic cell-cell adhesion [BP],
8-hydroxy-dADP phosphatase activity [MF] |
| CG_ffipsc69_promoter_n_RM_14_34_2 |
 |
 |
4 |
0.4 |
2.65E-04 |
SURF6,
TOLLIP |
granular component [CC],
interleukin-1, Type I receptor binding [MF],
interleukin-18 receptor complex [CC],
interleukin-1 receptor complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_50_6 |
 |
 |
6 |
1.0 |
4.62E-04 |
GAS1,
LUZP1,
HYI,
TRIM9 |
hydroxypyruvate isomerase activity [MF],
neural fold bending [BP],
negative regulation of mitotic cell cycle [BP],
negative regulation of SNARE complex assembly [BP] |
| CG_ffipsc69_promoter_n_RM_12_160_14 |
 |
 |
6 |
1.0 |
2.98E-04 |
ASH1L,
IMPAD1,
CHSY1,
PDGFA |
3'-nucleotidase activity [MF],
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
chondroitin sulfate metabolic process [BP],
Golgi apparatus [CC] |
| CG_ffipsc69_promoter_n_RM_12_262_8 |
 |
 |
4 |
0.8 |
2.98E-04 |
MESP1,
RAF1,
CEBPD,
RACGAP1,
VOPP1,
EVC2,
GNB2L1,
ZNF682,
CDKN2A,
NKX3-1,
LAS1L,
MLXIPL,
PIK3C2B,
RAB3D,
CFL1,
GMEB2,
SOS1,
TOLLIP,
CDC26,
EPC1,
UBTD2,
MBD3,
PRDX1 |
heterochromatin [CC],
positive regulation of protein sumoylation [BP],
intracellular signal transduction [BP],
activation of cysteine-type endopeptidase activity involved in apoptotic process [BP],
regulation of cell division [BP],
GTP catabolic process [BP],
positive regulation of intrinsic apoptotic signaling pathway [BP],
signal transduction [BP],
nucleus [CC],
cell division [BP] |
| CG_ffipsc69_promoter_n_RM_12_207_15 |
 |
 |
6 |
0.8 |
3.72E-04 |
DLG4,
PDGFA,
LAMA1 |
P2Y1 nucleotide receptor binding [MF],
branching involved in salivary gland morphogenesis [BP],
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP] |
| CG_ffipsc69_promoter_n_RM_14_2_7 |
 |
 |
7 |
0.8 |
3.84E-04 |
CLOCK,
GLIS1,
PINX1,
NKX2-8,
GBX1,
UBQLN1,
CIAPIN1,
STAP2,
PERP,
DGCR6L,
NEUROG2,
PIP4K2B,
ZBTB2,
ZZZ3,
LBX2,
TXNL1,
SP3,
EVX2,
BARX1,
POLR2I,
MEX3C,
NKX6-1,
TAF12,
AKT2,
HOXA1,
SMEK2,
GAS1,
CUL3,
HDAC4 |
transcription regulatory region DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
sequence-specific DNA binding [MF],
trophectodermal cell differentiation [BP],
outer ear morphogenesis [BP],
DNA binding [MF],
regulation of cardiac muscle contraction by calcium ion signaling [BP],
nucleus [CC] |
| CG_ffipsc69_promoter_n_RM_14_3_6 |
 |
 |
5 |
0.6 |
2.25E-04 |
VCPIP1,
TGFB1 |
defense response to fungus, incompatible interaction [BP],
negative regulation of hyaluronan biosynthetic process [BP],
positive regulation of NAD+ ADP-ribosyltransferase activity [BP],
Golgi reassembly [BP] |
| CG_ffipsc69_promoter_n_RM_12_1_10 |
 |
 |
3 |
0.6 |
4.12E-05 |
PLXNB1,
PODXL |
regulation of microvillus assembly [BP],
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_14_32_2 |
 |
 |
2 |
0.4 |
1.50E-04 |
DNA2,
EPHA4 |
DH domain binding [MF],
helicase activity [MF],
gamma DNA polymerase complex [CC],
fasciculation of motor neuron axon [BP],
mitochondrial DNA repair [BP],
site-specific endodeoxyribonuclease activity, specific for altered base [MF],
fasciculation of sensory neuron axon [BP],
positive regulation of Rho guanyl-nucleotide exchange factor activity [BP] |
| CG_ffipsc69_promoter_n_RM_12_56_5 |
 |
 |
5 |
1.0 |
2.11E-04 |
FGL1,
IDI1 |
response to stilbenoid [BP] |
| CG_ffipsc69_promoter_n_RM_12_247_4 |
 |
 |
4 |
0.8 |
3.83E-04 |
NKX3-1,
NKX6-1,
DLX2 |
negative regulation of glial cell differentiation [BP],
transcription regulatory region sequence-specific DNA binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_47_6 |
 |
 |
4 |
0.8 |
3.18E-04 |
LATS2,
TEAD2 |
hippo signaling cascade [BP] |
| CG_ffipsc69_promoter_n_RM_12_278_6 |
 |
 |
3 |
0.4 |
1.70E-04 |
ICMT,
SLC19A1 |
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF],
methotrexate transport [BP],
regulation of Ras protein signal transduction [BP],
methotrexate transporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_145_7 |
 |
 |
6 |
1.0 |
1.73E-04 |
IP6K1,
INPP5K |
phosphatidylinositol phosphorylation [BP] |
| CG_ffipsc69_promoter_n_RM_12_283_5 |
 |
 |
6 |
0.8 |
2.49E-04 |
TNFRSF10D,
SLC33A1,
TNFRSF10B |
TRAIL binding [MF],
acetyl-CoA transporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_60_4 |
 |
 |
4 |
0.8 |
3.11E-04 |
SLC23A1,
GFI1,
RACGAP1 |
cytokinesis, actomyosin contractile ring assembly [BP],
cytokinesis, initiation of separation [BP],
dehydroascorbic acid transport [BP],
positive regulation of interleukin-6-mediated signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_14_35_5 |
 |
 |
4 |
0.6 |
4.24E-04 |
MPPE1,
NTAN1 |
endoplasmic reticulum exit site [CC],
protein-N-terminal asparagine amidohydrolase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_124_5 |
 |
 |
3 |
0.6 |
1.20E-04 |
PPT1,
BAZ1A |
protein depalmitoylation [BP],
ACF complex [CC],
CHRAC [CC] |
| CG_ffipsc69_promoter_n_RM_12_248_9 |
 |
 |
3 |
0.6 |
2.18E-04 |
CYGB,
TBX15,
NGB,
BAK1,
SLC4A11 |
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
borate transmembrane transporter activity [MF],
borate transport [BP],
oxygen transporter activity [MF],
Tle3-Aes complex [CC],
oxygen binding [MF],
oxygen transport [BP],
response to mycotoxin [BP],
borate transmembrane transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_209_4 |
 |
 |
3 |
0.6 |
1.48E-04 |
DOK4,
DLX2,
LHX5 |
forebrain neuron differentiation [BP],
hippocampus development [BP],
nervous system development [BP] |
| CG_ffipsc69_promoter_n_RM_14_19_3 |
 |
 |
5 |
0.8 |
3.09E-04 |
WNT7A,
MLXIPL |
glucose mediated signaling pathway [BP],
carbohydrate response element binding [MF],
Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells [BP] |
| CG_ffipsc69_promoter_n_RM_12_222_10 |
 |
 |
1 |
0.2 |
3.44E-04 |
EPOR |
erythropoietin receptor activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_201_6 |
 |
 |
4 |
0.8 |
3.62E-04 |
CITED2 |
adrenal cortex formation [BP] |
| CG_ffipsc69_promoter_n_RM_12_63_10 |
 |
 |
5 |
1.0 |
1.85E-04 |
SLC30A2 |
positive regulation of sequestering of zinc ion [BP] |
| CG_ffipsc69_promoter_n_RM_12_67_6 |
 |
 |
4 |
0.6 |
7.39E-04 |
THRB,
NFIB,
GSK3A |
negative regulation of type B pancreatic cell development [BP],
negative regulation of mesenchymal cell proliferation involved in lung development [BP],
negative regulation of cell growth involved in cardiac muscle cell development [BP],
female courtship behavior [BP],
positive regulation of adrenergic receptor signaling pathway [BP],
negative regulation of UDP-glucose catabolic process [BP],
cerebellar mossy fiber [CC],
Type I pneumocyte differentiation [BP],
negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP],
enzyme binding [MF],
principal sensory nucleus of trigeminal nerve development [BP] |
| CG_ffipsc69_promoter_n_RM_12_59_6 |
 |
 |
3 |
0.6 |
3.42E-04 |
CYBA,
UFSP1,
NOX4,
BAZ1B |
UFM1 hydrolase activity [MF],
superoxide anion generation [BP],
negative regulation of glomerular filtration by angiotensin [BP],
superoxide-generating NADPH oxidase activity [MF],
vitamin D receptor activator activity [MF],
superoxide metabolic process [BP],
NADPH oxidase complex [CC],
smooth muscle hypertrophy [BP],
cellular response to gamma radiation [BP],
DNA replication-dependent nucleosome disassembly [BP] |
| CG_ffipsc69_promoter_n_RM_12_251_3 |
 |
 |
3 |
0.6 |
2.13E-04 |
SMAD7,
FOXA1 |
negative regulation of epithelial to mesenchymal transition [BP],
positive regulation of cell-cell adhesion [BP] |
| CG_ffipsc69_promoter_n_RM_14_14_5 |
 |
 |
9 |
1.0 |
3.00E-04 |
COQ2,
PRHOXNB |
4-hydroxybenzoate decaprenyltransferase activity [MF],
4-hydroxybenzoate nonaprenyltransferase activity [MF],
urate catabolic process [BP],
allantoin biosynthetic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_77_5 |
 |
 |
3 |
0.6 |
2.79E-04 |
NUDT3,
EIF2B3,
EIF4E3 |
diphosphoinositol polyphosphate catabolic process [BP],
translation initiation factor activity [MF],
diadenosine polyphosphate catabolic process [BP],
translation factor activity, nucleic acid binding [MF] |
| CG_ffipsc69_promoter_n_RM_14_13_3 |
 |
 |
3 |
0.4 |
4.78E-04 |
FASN |
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF],
oleoyl-[acyl-carrier-protein] hydrolase activity [MF],
myristoyl-[acyl-carrier-protein] hydrolase activity [MF],
[acyl-carrier-protein] S-malonyltransferase activity [MF],
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF],
[acyl-carrier-protein] S-acetyltransferase activity [MF],
3-oxoacyl-[acyl-carrier-protein] synthase activity [MF],
palmitoyl-[acyl-carrier-protein] hydrolase activity [MF],
3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF],
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF] |
| CG_ffipsc69_promoter_n_RM_16_3_2 |
 |
 |
5 |
0.4 |
2.28E-04 |
PITPNA,
ROCK2,
SLC27A5 |
cholate-CoA ligase activity [MF],
stearic acid binding [MF],
positive regulation of centrosome duplication [BP] |
| CG_ffipsc69_promoter_n_RM_12_258_9 |
 |
 |
8 |
1.0 |
2.48E-04 |
AKR7A3,
AK2 |
sperm mitochondrial sheath [CC],
aflatoxin catabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_133_8 |
 |
 |
3 |
0.6 |
1.99E-04 |
GLI3 |
lambdoid suture morphogenesis [BP],
sagittal suture morphogenesis [BP],
lateral semicircular canal development [BP],
lateral ganglionic eminence cell proliferation [BP],
anterior semicircular canal development [BP] |
| CG_ffipsc69_promoter_n_RM_12_287_8 |
 |
 |
4 |
0.6 |
3.28E-04 |
TLR9,
GLRX2,
TXN,
PYCARD |
positive regulation of tumor necrosis factor production [BP],
positive regulation of interleukin-6 production [BP],
peptide disulfide oxidoreductase activity [MF],
positive regulation of chemokine production [BP],
protein disulfide oxidoreductase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_152_14 |
 |
 |
6 |
1.0 |
3.30E-04 |
MKI67 |
condensed chromosome [CC],
chromosome, centromeric region [CC] |
| CG_ffipsc69_promoter_n_RM_12_79_4 |
 |
 |
5 |
0.8 |
1.17E-04 |
EFEMP2,
NKX3-1,
LAMA1 |
MADS box domain binding [MF],
salivary gland development [BP],
basement membrane [CC],
positive regulation of androgen secretion [BP],
extracellular matrix structural constituent [MF],
laminin-3 complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_70_4 |
 |
 |
2 |
0.4 |
1.63E-04 |
MYO1C,
PPT1 |
protein depalmitoylation [BP],
myosin I complex [CC],
positive regulation of vascular endothelial growth factor signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_12_285_6 |
 |
 |
8 |
1.0 |
2.53E-04 |
STAT1,
TFAP2A |
RNA polymerase II core promoter sequence-specific DNA binding [MF] |
| CG_ffipsc69_promoter_n_RM_14_21_1 |
 |
 |
2 |
0.4 |
3.33E-04 |
NKX3-1,
TXN |
androgen receptor activity [MF],
negative regulation of estrogen receptor binding [BP],
cellular response to drug [BP],
MADS box domain binding [MF],
response to thyroxine stimulus [BP],
positive regulation of androgen secretion [BP],
antibiotic metabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_16_5_1 |
 |
 |
1 |
0.2 |
8.92E-05 |
PKMYT1,
POLE |
base-excision repair, gap-filling [BP],
G1/S transition of mitotic cell cycle [BP] |
| CG_ffipsc69_promoter_n_RM_12_17_6 |
 |
 |
3 |
0.6 |
2.19E-04 |
CDO1,
TMEM229A,
SLC4A11 |
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
taurine biosynthetic process [BP],
borate transmembrane transporter activity [MF],
borate transport [BP],
cysteine dioxygenase activity [MF],
host cell nucleus [CC],
L-cysteine catabolic process [BP],
borate transmembrane transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_137_9 |
 |
 |
2 |
0.4 |
2.23E-04 |
AIFM2 |
chromosome condensation [BP] |
| CG_ffipsc69_promoter_n_RM_12_46_6 |
 |
 |
4 |
0.6 |
1.70E-04 |
SLC30A2 |
positive regulation of sequestering of zinc ion [BP] |
| CG_ffipsc69_promoter_n_RM_12_29_6 |
 |
 |
5 |
1.0 |
2.72E-04 |
MMS19,
TXN |
response to thyroxine stimulus [BP],
phosphorelay signal transduction system [BP] |
| CG_ffipsc69_promoter_n_RM_12_261_3 |
 |
 |
5 |
0.8 |
2.20E-04 |
HOXA13,
ADCY9,
EN1,
PRKAR1B,
FEZF1,
HEG1 |
olfactory bulb development [BP],
activation of protein kinase A activity [BP],
embryonic forelimb morphogenesis [BP],
endothelial cell morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_244_5 |
 |
 |
2 |
0.4 |
7.99E-05 |
SLC30A2,
AASS |
saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [MF],
positive regulation of sequestering of zinc ion [BP],
saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_175_9 |
 |
 |
7 |
0.8 |
4.04E-04 |
SEMA7A,
RPS6KA5,
WASL,
RHOC |
axon guidance [BP] |
| CG_ffipsc69_promoter_n_RM_14_31_2 |
 |
 |
3 |
0.6 |
2.21E-04 |
PSME4,
UBR1,
HMGCS1 |
organic acid binding [MF],
proteasome complex [CC],
response to tellurium ion [BP],
response to low light intensity stimulus [BP] |
| CG_ffipsc69_promoter_n_RM_12_113_11 |
 |
 |
5 |
0.8 |
1.64E-04 |
ALG12 |
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [MF],
alpha-1,6-mannosyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_132_11 |
 |
 |
3 |
0.6 |
3.65E-04 |
CXCR4,
SFRP2 |
patterning of blood vessels [BP] |
| CG_ffipsc69_promoter_n_RM_12_131_8 |
 |
 |
4 |
0.8 |
2.19E-04 |
TOPORS,
PAK1,
FGF14,
DDX17 |
positive regulation of intracellular estrogen receptor signaling pathway [BP],
JNK cascade [BP],
antigen binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_142_6 |
 |
 |
4 |
0.8 |
2.81E-04 |
DLL1,
ADAM10 |
Notch receptor processing [BP] |
| CG_ffipsc69_promoter_n_RM_12_18_11 |
 |
 |
2 |
0.4 |
2.60E-04 |
ALG12,
JAG1,
RERE |
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [MF],
poly-glutamine tract binding [MF],
endocardial cushion cell development [BP],
alpha-1,6-mannosyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_14_8_3 |
 |
 |
3 |
0.4 |
2.16E-04 |
UROS |
cellular response to amine stimulus [BP],
uroporphyrinogen-III synthase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_20_8 |
 |
 |
5 |
1.0 |
2.62E-04 |
CDC25A,
NBN,
ZRANB3,
E2F8,
SLC16A1 |
DNA rewinding [BP],
DNA replication [BP],
mevalonate transport [BP],
cell cycle comprising mitosis without cytokinesis [BP],
replication fork [CC] |
| CG_ffipsc69_promoter_n_RM_12_253_6 |
 |
 |
3 |
0.6 |
1.28E-04 |
IDH1,
CRYZL1 |
NADP binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_170_8 |
 |
 |
5 |
0.8 |
2.28E-04 |
SPRY2,
AES,
PTCH1,
HDAC5,
HOXB2 |
multicellular organismal development [BP],
negative regulation of osteoblast differentiation [BP],
branching morphogenesis of an epithelial tube [BP] |
| CG_ffipsc69_promoter_n_RM_12_144_8 |
 |
 |
5 |
1.0 |
3.45E-04 |
GCH1,
YES1,
VAV2,
UCN |
epidermal growth factor receptor binding [MF],
regulation of vascular permeability [BP],
response to pain [BP] |
| CG_ffipsc69_promoter_n_RM_12_239_7 |
 |
 |
8 |
0.8 |
3.80E-04 |
P4HB,
ADCY9,
PRKAR1B,
KIAA0368,
MPPE1 |
activation of protein kinase A activity [BP],
endoplasmic reticulum-Golgi intermediate compartment [CC] |
| CG_ffipsc69_promoter_n_RM_12_176_10 |
 |
 |
5 |
1.0 |
4.31E-04 |
PLCB2,
SOCS3,
CDKN1C,
PLCD3,
ADAM17,
LIPA |
lipase activity [MF],
lipid catabolic process [BP],
phospholipase C activity [MF],
placenta blood vessel development [BP],
phosphatidylinositol phospholipase C activity [MF],
placenta development [BP],
JAK-STAT cascade involved in growth hormone signaling pathway [BP],
positive regulation of transforming growth factor beta receptor signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_12_19_9 |
 |
 |
4 |
0.8 |
2.72E-04 |
TJP1,
COL4A3BP,
TEAD3 |
ceramide transporter activity [MF],
hippo signaling cascade [BP],
cell-cell signaling involved in cell-cell junction organization [BP] |
| CG_ffipsc69_promoter_n_RM_12_173_8 |
 |
 |
3 |
0.6 |
4.49E-04 |
NDN,
FEZF2 |
axonal fasciculation [BP] |
| CG_ffipsc69_promoter_n_RM_12_226_9 |
 |
 |
2 |
0.4 |
8.92E-05 |
TTLL1,
MSRB1,
ERO1LB |
oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [MF],
tubulin-glutamic acid ligase activity [MF],
methionine-R-sulfoxide reductase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_88_5 |
 |
 |
4 |
0.8 |
2.85E-04 |
LHX6,
TFAP2A,
RORA,
PVRL1,
GLI3,
NKX3-1,
CREB3L2 |
forebrain neuron development [BP],
sequence-specific DNA binding transcription factor activity [MF],
camera-type eye morphogenesis [BP],
sequence-specific DNA binding [MF],
lens morphogenesis in camera-type eye [BP],
metanephros development [BP],
cerebral cortex radially oriented cell migration [BP] |
| CG_ffipsc69_promoter_n_RM_12_61_7 |
 |
 |
3 |
0.4 |
1.45E-04 |
LBX1,
ADCY3,
NPY1R |
regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP],
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_12_78_8 |
 |
 |
5 |
1.0 |
2.31E-04 |
PAXIP1,
LARGE |
chorion development [BP],
glycosphingolipid biosynthetic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_252_2 |
 |
 |
3 |
0.6 |
1.82E-04 |
ABCB6,
SLC40A1 |
heme-transporting ATPase activity [MF],
cellular iron ion homeostasis [BP],
spleen trabecula formation [BP] |
| CG_ffipsc69_promoter_n_RM_12_123_4 |
 |
 |
4 |
0.6 |
1.97E-04 |
SALL1,
IMMP2L,
DMRTA2 |
mitochondrial inner membrane peptidase complex [CC],
inductive cell-cell signaling [BP],
sex differentiation [BP] |
| CG_ffipsc69_promoter_n_RM_12_259_12 |
 |
 |
8 |
1.0 |
3.60E-04 |
LAMA5,
C14orf39,
IRS2,
EBF2,
ADAM17,
BCL6,
SPATA6,
RECQL4 |
positive regulation of cellular component movement [BP],
negative regulation of B cell apoptotic process [BP],
multicellular organismal development [BP],
establishment of protein localization to plasma membrane [BP] |
| CG_ffipsc69_promoter_n_RM_12_8_3 |
 |
 |
2 |
0.4 |
2.67E-04 |
MBOAT4,
SLC23A1 |
dehydroascorbic acid transport [BP],
peptidyl-serine octanoylation [BP],
serine O-acyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_15_11 |
 |
 |
6 |
1.0 |
2.76E-04 |
LGI4 |
myelination in peripheral nervous system [BP] |
| CG_ffipsc69_promoter_n_RM_12_269_4 |
 |
 |
4 |
0.8 |
8.14E-05 |
NTN4,
SNAPC4,
BCL2L1 |
snRNA-activating protein complex [CC],
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling [BP],
snRNA transcription from RNA polymerase III promoter [BP],
snRNA transcription from RNA polymerase II promoter [BP],
response to cycloheximide [BP] |
| CG_ffipsc69_promoter_n_RM_12_167_4 |
 |
 |
3 |
0.6 |
2.56E-04 |
RNF41,
FOXM1 |
regulation of reactive oxygen species metabolic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_165_7 |
 |
 |
1 |
0.2 |
5.65E-05 |
LPXN,
STRA13 |
negative regulation of B cell receptor signaling pathway [BP],
FANCM-MHF complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_12_5 |
 |
 |
4 |
0.6 |
1.91E-04 |
HSP90AA1 |
protein refolding [BP] |
| CG_ffipsc69_promoter_n_RM_12_190_7 |
 |
 |
2 |
0.4 |
3.31E-04 |
HNF1B |
mesonephric duct formation [BP],
hepatoblast differentiation [BP],
pronephric nephron tubule development [BP],
regulation of pronephros size [BP] |
| CG_ffipsc69_promoter_n_RM_16_2_4 |
 |
 |
9 |
1.0 |
4.69E-04 |
AKT2,
WASL,
PODXL |
lamellipodium [CC] |
| CG_ffipsc69_promoter_n_RM_12_116_12 |
 |
 |
2 |
0.4 |
3.18E-04 |
PEG3,
NDN |
genetic imprinting [BP] |
| CG_ffipsc69_promoter_n_RM_12_164_3 |
 |
 |
7 |
1.0 |
1.51E-04 |
TNIP1,
ROCK1,
HBEGF |
negative regulation of elastin biosynthetic process [BP],
leukocyte cell-cell adhesion [BP],
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade [BP] |
| CG_ffipsc69_promoter_n_RM_12_177_15 |
 |
 |
3 |
0.6 |
2.94E-04 |
FEZF2,
PAX6 |
forebrain anterior/posterior pattern specification [BP] |
| CG_ffipsc69_promoter_n_RM_12_39_6 |
 |
 |
3 |
0.6 |
2.72E-04 |
AP3M1,
AP3D1 |
anterograde axon cargo transport [BP],
anterograde synaptic vesicle transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_11_6 |
 |
 |
4 |
0.8 |
3.94E-05 |
IRF7 |
establishment of viral latency [BP],
regulation of MyD88-independent toll-like receptor signaling pathway [BP] |
| CG_ffipsc69_promoter_n_RM_12_178_6 |
 |
 |
7 |
1.0 |
2.96E-04 |
HDDC3 |
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_215_9 |
 |
 |
4 |
0.8 |
3.36E-04 |
PIEZO2 |
mechanically-gated ion channel activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_45_12 |
 |
 |
4 |
0.8 |
2.83E-04 |
SALL1,
PMS2 |
somatic recombination of immunoglobulin gene segments [BP],
inductive cell-cell signaling [BP] |
| CG_ffipsc69_promoter_n_RM_12_163_6 |
 |
 |
2 |
0.4 |
2.43E-04 |
PRKAG3 |
cell cycle arrest [BP] |
| CG_ffipsc69_promoter_n_RM_12_108_14 |
 |
 |
4 |
0.8 |
4.25E-04 |
JAK3,
PLXND1 |
semaphorin-plexin signaling pathway [BP],
regulation of T cell apoptotic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_65_5 |
 |
 |
4 |
0.8 |
3.02E-04 |
PEMT,
LUZP1 |
neural fold bending [BP],
phosphatidylethanolamine N-methyltransferase activity [MF],
phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF],
phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_27_6 |
 |
 |
5 |
1.0 |
3.30E-04 |
NKX3-1,
SLC30A2,
FOXI3 |
positive regulation of androgen secretion [BP],
MADS box domain binding [MF],
pattern specification process [BP],
positive regulation of sequestering of zinc ion [BP] |
| CG_ffipsc69_promoter_n_RM_16_7_1 |
 |
 |
3 |
0.6 |
9.97E-04 |
AURKB |
cleavage furrow formation [BP],
spindle midzone assembly involved in mitosis [BP],
chromosome passenger complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_217_6 |
 |
 |
8 |
1.0 |
2.58E-04 |
HACE1,
CEBPD,
CHD8,
AHNAK,
SIX1,
ZFP36L2,
TTF1,
VCP,
STAT5B,
MLF2,
SALL1,
USP28,
NEUROG1,
SOX18 |
positive regulation of transcription, DNA-dependent [BP],
transcription from RNA polymerase II promoter [BP],
sequence-specific DNA binding transcription factor activity [MF],
epithelial cell differentiation [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
transcription regulatory region DNA binding [MF],
chromatin binding [MF],
DNA binding [MF],
cell fate commitment [BP],
nucleus [CC] |
| CG_ffipsc69_promoter_n_RM_12_76_6 |
 |
 |
3 |
0.6 |
1.94E-04 |
SLC23A1 |
dehydroascorbic acid transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_158_12 |
 |
 |
5 |
0.6 |
3.38E-04 |
SH2D2A,
BCAR1,
SCTR |
secretin receptor activity [MF],
SH3 domain binding [MF] |
| CG_ffipsc69_promoter_n_RM_14_12_3 |
 |
 |
5 |
0.8 |
1.94E-04 |
TKT |
glyceraldehyde-3-phosphate biosynthetic process [BP],
xylulose biosynthetic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_139_8 |
 |
 |
4 |
0.6 |
4.37E-04 |
CKAP5,
TGDS |
dTDP-glucose 4,6-dehydratase activity [MF],
establishment or maintenance of microtubule cytoskeleton polarity [BP] |
| CG_ffipsc69_promoter_n_RM_12_206_12 |
 |
 |
5 |
0.8 |
2.79E-04 |
CDK6,
DRD1,
CARD9 |
astrocyte development [BP],
dentate gyrus development [BP],
regulation of interleukin-6 biosynthetic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_81_5 |
 |
 |
9 |
1.0 |
1.82E-04 |
CDX2,
SIN3A,
CITED2 |
RNA polymerase II transcription corepressor activity [MF],
trophectodermal cell differentiation [BP],
RNA polymerase II activating transcription factor binding [MF] |
| CG_ffipsc69_promoter_n_RM_14_20_2 |
 |
 |
3 |
0.6 |
3.18E-04 |
ZNF442,
ZNF443,
ZNF799,
ZNF823,
HIST1H1A,
HIST1H1B,
ZNF44 |
nucleosome [CC],
DNA binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_23_3 |
 |
 |
6 |
0.8 |
4.13E-04 |
TAX1BP3,
TOB2,
LMO1,
NCAPD3,
APPL2,
RANBP9,
SEPSECS,
DQX1,
EVX2,
STRADA,
GALNT3,
METTL8 |
nuclear condensin complex [CC],
nucleus [CC] |
| CG_ffipsc69_promoter_n_RM_12_263_3 |
 |
 |
4 |
0.6 |
4.19E-04 |
GAREM,
NKX3-1,
JAG1 |
positive regulation of androgen secretion [BP],
MADS box domain binding [MF],
positive regulation of cell division [BP],
endocardial cushion cell development [BP] |
| CG_ffipsc69_promoter_n_RM_12_83_7 |
 |
 |
5 |
0.8 |
3.98E-04 |
MOGS,
POLD2 |
mannosyl-oligosaccharide glucosidase activity [MF],
base-excision repair [BP] |
| CG_ffipsc69_promoter_n_RM_12_220_5 |
 |
 |
5 |
1.0 |
2.96E-04 |
CEBPD,
CDX2,
TFEB,
MED1,
OTP,
ETS1,
CERS2 |
embryonic placenta development [BP],
sequence-specific DNA binding transcription factor activity [MF],
hypothalamus development [BP] |
| CG_ffipsc69_promoter_n_RM_12_271_12 |
 |
 |
4 |
0.6 |
1.93E-04 |
HOXA5,
MOB1A,
LATS2 |
cell-cell signaling involved in mammary gland development [BP],
hippo signaling cascade [BP] |
| CG_ffipsc69_promoter_n_RM_12_228_8 |
 |
 |
3 |
0.6 |
3.11E-04 |
AXIN2,
LATS2 |
regulation of mismatch repair [BP],
negative regulation of canonical Wnt receptor signaling pathway [BP],
regulation of chondrocyte development [BP] |
| CG_ffipsc69_promoter_n_RM_12_184_6 |
 |
 |
3 |
0.6 |
2.45E-04 |
DLG4,
CNN3,
HRAS,
MYO1A,
PLXND1,
HSP90AA1,
SLC8A2,
PITPNA,
NRP1,
KCNH5 |
dichotomous subdivision of terminal units involved in salivary gland branching [BP],
chemotaxis [BP],
calmodulin binding [MF],
axon guidance [BP],
semaphorin-plexin signaling pathway [BP],
semaphorin receptor activity [MF] |
| CG_ffipsc69_promoter_n_RM_14_44_3 |
 |
 |
7 |
1.0 |
5.57E-04 |
ALG2,
GNB1,
ANAPC7,
GNG7,
MAD1L1 |
protein glycosylation in endoplasmic reticulum [BP],
mitotic cell cycle spindle assembly checkpoint [BP],
GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF],
mitotic telophase [BP],
cellular response to glucagon stimulus [BP],
heterotrimeric G-protein complex [CC] |
| CG_ffipsc69_promoter_n_RM_12_198_3 |
 |
 |
2 |
0.4 |
2.92E-04 |
NAGA |
alpha-N-acetylgalactosaminidase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_213_4 |
 |
 |
7 |
1.0 |
3.73E-04 |
MLLT3 |
segment specification [BP] |
| CG_ffipsc69_promoter_n_RM_12_104_6 |
 |
 |
6 |
1.0 |
3.88E-04 |
OCA2,
PGM3 |
arsenite transport [BP],
phosphoacetylglucosamine mutase activity [MF],
tyrosine transport [BP],
arsenite transmembrane transporter activity [MF],
L-tyrosine transmembrane transporter activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_126_5 |
 |
 |
2 |
0.4 |
2.53E-04 |
M1AP |
male meiosis chromosome separation [BP] |
| CG_ffipsc69_promoter_n_RM_12_188_7 |
 |
 |
3 |
0.6 |
3.88E-04 |
HOOK2,
EEA1 |
early endosome to late endosome transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_232_9 |
 |
 |
4 |
0.8 |
2.34E-04 |
HMGB1,
IPMK,
HSPA12A,
CDK5,
STK38,
MYO5B,
MAFB,
IPPK,
SF3B14 |
inositol pentakisphosphate 2-kinase activity [MF],
negative regulation of apoptotic cell clearance [BP],
inositol tetrakisphosphate 3-kinase activity [MF],
inositol-1,4,5-trisphosphate 6-kinase activity [MF],
rhombomere 6 development [BP],
inositol phosphorylation [BP],
nucleotide binding [MF],
ATP binding [MF],
acetylcholine receptor activator activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_229_4 |
 |
 |
2 |
0.4 |
1.80E-04 |
TMED10,
CTGF |
cis-Golgi network [CC] |
| CG_ffipsc69_promoter_n_RM_12_157_8 |
 |
 |
4 |
0.8 |
1.52E-04 |
TXN,
CTBP1 |
regulation of transcription by chromatin organization [BP],
response to thyroxine stimulus [BP] |
| CG_ffipsc69_promoter_n_RM_12_110_6 |
 |
 |
5 |
1.0 |
4.00E-04 |
KIF17 |
protein complex localization [BP] |
| CG_ffipsc69_promoter_n_RM_12_230_8 |
 |
 |
3 |
0.6 |
2.39E-04 |
HSPD1,
COQ2,
MAP6D1,
WNK3,
NACC2 |
positive regulation of rubidium ion transmembrane transporter activity [BP],
positive regulation of T cell mediated immune response to tumor cell [BP],
N-terminal peptidyl-L-cysteine N-palmitoylation [BP],
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP],
4-hydroxybenzoate decaprenyltransferase activity [MF],
positive regulation of rubidium ion transport [BP],
4-hydroxybenzoate nonaprenyltransferase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_286_7 |
 |
 |
6 |
0.8 |
2.56E-04 |
COLEC12,
ZGLP1 |
pattern recognition receptor signaling pathway [BP],
oocyte development [BP] |
| CG_ffipsc69_promoter_n_RM_16_11_1 |
 |
 |
1 |
0.2 |
4.37E-04 |
TDP2 |
5'-tyrosyl-DNA phosphodiesterase activity [MF],
tyrosyl-RNA phosphodiesterase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_155_4 |
 |
 |
6 |
1.0 |
2.93E-04 |
ACSS1 |
acetate biosynthetic process [BP],
propionate biosynthetic process [BP] |
| CG_ffipsc69_promoter_n_RM_12_5_9 |
 |
 |
6 |
1.0 |
2.96E-04 |
GALNT3,
MPPE1 |
manganese ion binding [MF] |
| CG_ffipsc69_promoter_n_RM_12_89_7 |
 |
 |
5 |
0.8 |
9.47E-05 |
MYO10 |
cytoskeleton-dependent intracellular transport [BP] |
| CG_ffipsc69_promoter_n_RM_12_90_10 |
 |
 |
7 |
1.0 |
4.09E-04 |
SMAD7,
CNKSR3,
TBX3 |
negative regulation of peptidyl-serine phosphorylation [BP],
ventricular septum morphogenesis [BP] |
| CG_ffipsc69_promoter_n_RM_12_87_3 |
 |
 |
3 |
0.6 |
2.55E-04 |
UFSP1 |
UFM1 hydrolase activity [MF] |
| CG_ffipsc69_promoter_n_RM_12_172_3 |
 |
 |
2 |
0.4 |
3.51E-04 |
GDF2,
CDAN1 |
negative regulation of DNA replication [BP] |
| CG_ffipsc69_promoter_n_RM_12_192_11 |
 |
 |
7 |
1.0 |
2.35E-04 |
SREBF1,
GPLD1,
SIX1,
PTK2,
BCL11A |
positive regulation of triglyceride biosynthetic process [BP],
negative regulation of axonogenesis [BP],
negative regulation of collateral sprouting [BP],
regulation of neuron differentiation [BP] |
| CG_ffipsc69_promoter_n_RM_12_219_10 |
 |
 |
2 |
0.4 |
1.99E-04 |
EAPP,
TSNARE1,
NELFE,
DOC2B |
SNARE complex [CC],
negative regulation of transcription elongation from RNA polymerase II promoter [BP] |